Toll Free: 1-888-928-9744
Published: Feb, 2017 | Pages:
187 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Post-Operative Pain - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H1 2017, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape. Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 1, 9, 16, 10, 13, 3 and 1 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 1 molecules, respectively. Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System). - The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Post-Operative Pain - Overview 8 Post-Operative Pain - Therapeutics Development 9 Pipeline Overview 9 Pipeline by Companies 10 Pipeline by Universities/Institutes 14 Products under Development by Companies 15 Products under Development by Universities/Institutes 19 Post-Operative Pain - Therapeutics Assessment 20 Assessment by Target 20 Assessment by Mechanism of Action 23 Assessment by Route of Administration 26 Assessment by Molecule Type 28 Post-Operative Pain - Companies Involved in Therapeutics Development 30 AcelRx Pharmaceuticals Inc 30 Adynxx Inc 30 AngioChem Inc 31 Aoxing Pharmaceutical Company Inc 31 AskAt Inc 31 Boehringer Ingelheim GmbH 32 Camurus AB 33 Cara Therapeutics Inc 33 Colby Pharmaceutical Company 34 Cytogel Pharma LLC 34 Dompe Farmaceutici SpA 35 DURECT Corp 35 Eupraxia Pharmaceuticals Inc 36 EyeGate Pharmaceuticals Inc 36 Fujimoto Pharmaceutical Corp 37 Grunenthal GmbH 37 GW Pharmaceuticals Plc 38 Heron Therapeutics Inc 38 Immupharma Plc 39 Innocoll AG 39 INSYS Therapeutics Inc 40 iX Biopharma Ltd 40 Laboratorios Del Dr Esteve SA 41 Lipocure Ltd 41 Liquidia Technologies Inc 42 Medtronic Plc 42 Novartis AG 43 Orbis Biosciences Inc 43 Orion Oyj 44 Pacira Pharmaceuticals Inc 44 PainReform Ltd 45 Pharmazz Inc 45 PhytoHealth Corp 46 PixarBio Corp 46 Proteus SA 47 Recro Pharma Inc 47 Relmada Therapeutics Inc 48 Serina Therapeutics Inc 48 SteadyMed Therapeutics Inc 49 Teikoku Pharma USA Inc 49 The Medicines Company 50 Trevena Inc 50 Post-Operative Pain - Drug Profiles 51 (bupivacaine hydrochloride + meloxicam) ER - Drug Profile 51 (buprenorphine hydrochloride + granisetron hydrochloride) ER - Drug Profile 54 A-100 - Drug Profile 55 ANG-2002 - Drug Profile 56 ARX-04 - Drug Profile 57 AYX-1 - Drug Profile 64 BI-1026706 - Drug Profile 67 bupivacaine hydrochloride - Drug Profile 69 bupivacaine hydrochloride - Drug Profile 70 bupivacaine hydrochloride - Drug Profile 71 bupivacaine hydrochloride - Drug Profile 72 bupivacaine hydrochloride SR - Drug Profile 74 bupivacaine hydrochloride SR - Drug Profile 79 buprenorphine hydrochloride - Drug Profile 80 CAM-2048 - Drug Profile 81 carbamazepine - Drug Profile 82 CPC-111 - Drug Profile 83 CPC-123 - Drug Profile 84 Cyt-1010 - Drug Profile 85 dexamethasone acetate - Drug Profile 87 dexmedetomidine hydrochloride - Drug Profile 92 DF-2755A - Drug Profile 93 difelikefalin - Drug Profile 94 ECP-1014 - Drug Profile 103 fadolmidine hydrochloride - Drug Profile 104 fentanyl - Drug Profile 105 gonyautoxin - Drug Profile 106 grapiprant - Drug Profile 107 HTX-009 - Drug Profile 109 HYLP-002 - Drug Profile 110 IPP-102199 - Drug Profile 111 ketamine hydrochloride - Drug Profile 112 ketorolac tromethamine - Drug Profile 114 lacosamide - Drug Profile 115 levorphanol tartrate ER - Drug Profile 116 MDT-10013 - Drug Profile 118 meloxicam - Drug Profile 119 meloxicam ER - Drug Profile 123 MR-309 - Drug Profile 124 nabiximols - Drug Profile 126 nalbuphine hydrochloride - Drug Profile 133 neosaxitoxin - Drug Profile 134 oliceridine - Drug Profile 136 oxethazaine - Drug Profile 141 PMZ-2010 - Drug Profile 142 RBM-004 - Drug Profile 144 ropivacaine - Drug Profile 145 ropivacaine ER - Drug Profile 146 SAF-312 - Drug Profile 147 SER-226 - Drug Profile 148 Small Molecule for Post-Operative Pain - Drug Profile 149 sufentanil citrate - Drug Profile 150 tapentadol hydrochloride - Drug Profile 158 tilidine hydrochloride - Drug Profile 160 tramadol hydrochloride - Drug Profile 161 tramadol hydrochloride ER - Drug Profile 162 URB-937 - Drug Profile 163 VVZ-149 - Drug Profile 164 Post-Operative Pain - Dormant Projects 165 Post-Operative Pain - Discontinued Products 168 Post-Operative Pain - Product Development Milestones 169 Featured News & Press Releases 169 Appendix 182 Methodology 182 Coverage 182 Secondary Research 182 Primary Research 182 Expert Panel Validation 182 Contact Us 182 Disclaimer 183
List of Tables
Number of Products under Development for Post-Operative Pain, H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 Products under Development by Companies, H1 2017 Products under Development by Companies, H1 2017 (Contd..1), H1 2017 Products under Development by Companies, H1 2017 (Contd..2), H1 2017 Products under Development by Companies, H1 2017 (Contd..3), H1 2017 Products under Development by Universities/Institutes, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H1 2017 Post-Operative Pain - Pipeline by Adynxx Inc, H1 2017 Post-Operative Pain - Pipeline by AngioChem Inc, H1 2017 Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H1 2017 Post-Operative Pain - Pipeline by AskAt Inc, H1 2017 Post-Operative Pain - Pipeline by Boehringer Ingelheim GmbH, H1 2017 Post-Operative Pain - Pipeline by Camurus AB, H1 2017 Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H1 2017 Post-Operative Pain - Pipeline by Colby Pharmaceutical Company, H1 2017 Post-Operative Pain - Pipeline by Cytogel Pharma LLC, H1 2017 Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H1 2017 Post-Operative Pain - Pipeline by DURECT Corp, H1 2017 Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H1 2017 Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H1 2017 Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H1 2017 Post-Operative Pain - Pipeline by Grunenthal GmbH, H1 2017 Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H1 2017 Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H1 2017 Post-Operative Pain - Pipeline by Immupharma Plc, H1 2017 Post-Operative Pain - Pipeline by Innocoll AG, H1 2017 Post-Operative Pain - Pipeline by INSYS Therapeutics Inc, H1 2017 Post-Operative Pain - Pipeline by iX Biopharma Ltd, H1 2017 Post-Operative Pain - Pipeline by Laboratorios Del Dr Esteve SA, H1 2017 Post-Operative Pain - Pipeline by Lipocure Ltd, H1 2017 Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H1 2017 Post-Operative Pain - Pipeline by Medtronic Plc, H1 2017 Post-Operative Pain - Pipeline by Novartis AG, H1 2017 Post-Operative Pain - Pipeline by Orbis Biosciences Inc, H1 2017 Post-Operative Pain - Pipeline by Orion Oyj, H1 2017 Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H1 2017 Post-Operative Pain - Pipeline by PainReform Ltd, H1 2017 Post-Operative Pain - Pipeline by Pharmazz Inc, H1 2017 Post-Operative Pain - Pipeline by PhytoHealth Corp, H1 2017 Post-Operative Pain - Pipeline by PixarBio Corp, H1 2017 Post-Operative Pain - Pipeline by Proteus SA, H1 2017 Post-Operative Pain - Pipeline by Recro Pharma Inc, H1 2017 Post-Operative Pain - Pipeline by Relmada Therapeutics Inc, H1 2017 Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H1 2017 Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H1 2017 Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H1 2017 Post-Operative Pain - Pipeline by The Medicines Company, H1 2017 Post-Operative Pain - Pipeline by Trevena Inc, H1 2017 Post-Operative Pain - Dormant Projects, H1 2017 Post-Operative Pain - Dormant Projects, H1 2017 (Contd..1), H1 2017 Post-Operative Pain - Dormant Projects, H1 2017 (Contd..2), H1 2017 Post-Operative Pain - Discontinued Products, H1 2017
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.